Microfluidic-based human prostate-cancer-on-chip
Open accessThe DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Abstract
Lack of adequate models significantly hinders advances in prostate cancer treatment, where resistance to androgen-deprivation therapies and bone metastasis remain as major challenges. Current in vitro models fail to faithfully mimic the complex prostate physiology. In vivo animal models can shed light on the oncogenes involved in prostate cancer development and progression; however, the animal prostate gland is fundamentally different from that of human, and the underlying genetic mechanisms are different. To address this problem, we developed the first in vitro microfluidic human Prostate-Cancer-on-Chip (PCoC) model, where human prostate cancer and stromal fibroblast cells were co-cultivated in two channels separated by a porous membrane under culture medium flow. The established microenvironment enables soluble signaling factors secreted by each culture to locally diffuse through the membrane pores affecting the neighboring culture. We particularly explored the conversion of the stromal fibroblasts into cancer-associated fibroblasts (CAFs) due to the interaction between the 2 cell types. Immunofluorescence microscopy revealed that tumor cells induced CAF biomarkers, αSMA and COL1A1, in stromal fibroblasts. The stromal CAF conversion level was observed to increase along the flow direction in response to diffusion agents, consistent with simulations of solute concentration gradients. The tumor cells also downregulated androgen receptor (AR) expression in stromal fibroblasts, while an adequate level of stromal AR expression is maintained in normal prostate homeostasis. We further investigated tumor invasion into the stroma, an early step in the metastatic cascade, in devices featuring a serpentine channel with orthogonal channel segments overlaying a straight channel and separated by an 8 µm-pore membrane. Both tumor cells and stromal CAFs were observed to cross over into their neighboring channel, and the stroma’s role seemed to be proactive in promoting cell invasion. As control, normal epithelial cells neither induced CAF conversion nor promoted cell invasion. In summary, the developed PCoC model allows spatiotemporal analysis of the tumor-stroma dynamic interactions, due to bi-directional signaling and physical contact, recapitulating tissue-level multicellular responses associated with prostate cancer in vivo . Hence, it can serve as an in vitro model to dissect mechanisms in human prostate cancer development and seek advanced therapeutic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“To date, MPS models have been developed for the majority of human tissues and organs, and have also been established to study a diverse range of malignancies, including cancer (Baptista et al., 2022; Hachey et al. (2021; 2024); Jiang et al., 2024; Haque et al., 2022; Shen et al., 2023; Flont et al., 2023; Straehla et al., 2022).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Jiang et al., 2024
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Tumor chips have been developed to model a broad variety of cancers, including primary lung cancer, prostate cancer, breast cancer, colorectal cancer, pancreatic cancer, melanoma, liver cancer and glioblastoma (among other cancers), as well as cancer metastasis to the bone, the brain, the liver and the lung (Hachey et al. (2021; 2024); Jiang et al. (2024); Haque et al. (2022); Shen et al. (2023);”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Jiang et al., 2024
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Interestingly, the prostate tumor cells were able to drive the conversion of normal fibroblasts into CAFs, characterized by strong expression of aSMA and COL1A1, downregulation of AR and elongated morphology (Jiang et al., 2024).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Jiang et al., 2024
The cited source says what the claim attributes to it.
In the citing paper
“Prostate tumor cells drive the conversion of normal fibroblasts into CAFs, which promote tumor invasion via the secretion of TGF-β”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Jiang et al., 2024
The cited source says what the claim attributes to it.
In the citing paper
“In fact, both stromal CAFs and tumor cells migrated into the neighboring channel, suggesting that the stromal compartment plays a tumor invasion-promoting role via the secretion of TGF-β.”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Jiang et al., 2024
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“This is consistent with reported observations that stromal fi broblasts undergo a paralleled stromagenesis during tumorigenesis, becoming CAFs and actively participating in and promoting tumor growth and invasion, resembling tissue responses in wound healing (Dvorak, 1986).”
A framework for advancing our understanding of cancer-associated fibroblasts
Sahai, E., Astsaturov, I., Cukierman, E., DeNardo, D. G., Egeblad, M., Evans, R. M., Fearon, D., Greten, F. R., Hingorani, S. R., Hunter, T., et al. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0238-1 · Cited by 3,863
Human organoids: model systems for human biology and medicine
Kim, J., Koo, B.-K., & Knoblich, J. A. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0259-3 · Cited by 2,187
The extracellular matrix modulates the hallmarks of cancer
Pickup, M. W., Mouw, J. K., & Weaver, V. M. (2014) · EMBO reports · doi:10.15252/embr.201439246 · Cited by 1,996
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
Friedl, P., & Alexander, S. (2011) · Cell · doi:10.1016/j.cell.2011.11.016 · Cited by 1,940 · cited 2×
“Moreover, tumor cells invading the surrounding stroma further promote tumor progression mediated by the secretion of favorable factors from both cell types (Friedl and Alexander, 2011; Labernadie et al., 2017; Glentis et al., 2017; Almagro et al., 2022).”
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
Vermeulen, L., De Sousa E Melo, F., van der Heijden, M., Cameron, K., de Jong, J. H., Borovski, T., Tuynman, J. B., Todaro, M., Merz, C., Rodermond, H., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2048 · Cited by 1,804
Human organs-on-chips for disease modelling, drug development and personalized medicine
Ingber, D. E. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00466-9 · Cited by 1,589
Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium
Olumi, A., Grossfeld, G., Hayward, S., Carroll, P., Cunha, G., Hein, P., & Tlsty, T. (2000) · Breast Cancer Research · doi:10.1186/bcr138 · Cited by 1,463
Tuxhorn, J. A., Ayala, G. E., Smith, M. J., Smith, V. C., Dang, T. D., & Rowley, D. R. (2002) · PubMed · Cited by 885
Modes of cancer cell invasion and the role of the microenvironment
Clark, A. G., & Vignjevic, D. M. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.06.004 · Cited by 761
Labernadie, A., Kato, T., Brugués, A., Serra-Picamal, X., Derzsi, S., Arwert, E., Weston, A., González-Tarragó, V., Elosegui-Artola, A., Albertazzi, L., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3478 · Cited by 747
In search of definitions: Cancer‐associated fibroblasts and their markers
Nurmik, M., Ullmann, P., Rodriguez, F., Haan, S., & Letellier, E. (2020) · International Journal of Cancer · doi:10.1002/ijc.32193 · Cited by 739
Seyhan, A. A. (2019) · Translational Medicine Communications · doi:10.1186/s41231-019-0050-7 · Cited by 713
Collagen as a double-edged sword in tumor progression
Fang, M., Yuan, J., Peng, C., & Li, Y. (2014) · Tumor Biology · doi:10.1007/s13277-013-1511-7 · Cited by 580
Estimation of diffusion coefficients of proteins
Young, M. E., Carroad, P. A., & Bell, R. L. (1980) · Biotechnology and Bioengineering · doi:10.1002/bit.260220504 · Cited by 519
Lucas, J. M., Heinlein, C., Kim, T., Hernandez, S. A., Malik, M. S., True, L. D., Morrissey, C., Corey, E., Montgomery, B., Mostaghel, E., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-1010 · Cited by 468
Organoid Models of Tumor Immunology
Yuki, K., Cheng, N., Nakano, M., & Kuo, C. J. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.06.010 · Cited by 402
Cancer associated fibroblasts in cancer pathogenesis
Franco, O. E., Shaw, A. K., Strand, D. W., & Hayward, S. W. (2010) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2009.10.010 · Cited by 394
Glentis, A., Oertle, P., Mariani, P., Chikina, A., El Marjou, F., Attieh, Y., Zaccarini, F., Lae, M., Loew, D., Dingli, F., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00985-8 · Cited by 363
MOLECULAR INSIGHTS INTO PROSTATE CANCER PROGRESSION: THE MISSING LINK OF TUMOR MICROENVIRONMENT
CHUNG, L. W. K., BASEMAN, A., ASSIKIS, V., & ZHAU, H. E. (2005) · Journal of Urology · doi:10.1097/01.ju.0000141582.15218.10 · Cited by 361
Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ
Thompson, T. C., Southgate, J., Kitchener, G., & Land, H. (1989) · Cell · doi:10.1016/0092-8674(89)90625-9 · Cited by 352
Hayward, S. W., Dahiya, R., Cunha, G. R., Bartek, J., Deshpande, N., & Narayan, P. (1995) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/bf02631333 · Cited by 340
Cancer-associated fibroblasts lead tumor invasion through integrin-β3–dependent fibronectin assembly
Attieh, Y., Clark, A. G., Grass, C., Richon, S., Pocard, M., Mariani, P., Elkhatib, N., Betz, T., Gurchenkov, B., & Vignjevic, D. M. (2017) · Journal of Cell Biology · doi:10.1083/jcb.201702033 · Cited by 338
Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology
Ewart, L., Apostolou, A., Briggs, S. A., Carman, C. V., Chaff, J. T., Heng, A. R., Jadalannagari, S., Janardhanan, J., Jang, K.-J., Joshipura, S. R., et al. (2022) · Communications Medicine · doi:10.1038/s43856-022-00209-1 · Cited by 337
Jeong, S.-Y., Lee, J.-H., Shin, Y., Chung, S., & Kuh, H.-J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0159013 · Cited by 287
Periostin: A Matricellular Protein With Multiple Functions in Cancer Development and Progression
González-González, L., & Alonso, J. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00225 · Cited by 284
Francis, K., & Palsson, B. O. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12258 · Cited by 254
Challenges of Organoid Research
Andrews, M. G., & Kriegstein, A. R. (2022) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-111020-090812 · Cited by 250
Organs-on-a-chip models for biological research
Vunjak-Novakovic, G., Ronaldson-Bouchard, K., & Radisic, M. (2021) · Cell · doi:10.1016/j.cell.2021.08.005 · Cited by 248
Tumor-on-a-chip: from bioinspired design to biomedical application
Liu, X., Fang, J., Huang, S., Wu, X., Xie, X., Wang, J., Liu, F., Zhang, M., Peng, Z., & Hu, N. (2021) · Microsystems & Nanoengineering · doi:10.1038/s41378-021-00277-8 · Cited by 246
Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures
Kim, C. K., Lee, Y. R., Ong, L., Gold, M., Kalali, A., & Sarkar, J. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215699 · Cited by 241 · cited 1×
“More than 90% of cancer drugs, found ef fi cacious in animals, fail in human clinical trials because they are unsafe or ineffective in humans (Seyhan, 2019; Stensland et al., 2021; Stensland et al., 2022; Kim et al., 2022).”
Barcellos-de-Souza, P., Comito, G., Pons-Segura, C., Taddei, M. L., Gori, V., Becherucci, V., Bambi, F., Margheri, F., Laurenzana, A., Del Rosso, M., et al. (2016) · Stem Cells · doi:10.1002/stem.2412 · Cited by 230
Stromagenesis: The changing face of fibroblastic microenvironments during tumor progression
Beacham, D. A., & Cukierman, E. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.05.003 · Cited by 225
Henshall, S. M., Quinn, D. I., Lee, C. S., Head, D. R., Golovsky, D., Brenner, P. C., Delprado, W., Stricker, P. D., Grygiel, J. J., & Sutherland, R. L. (2001) · PubMed · Cited by 208
Prostate organogenesis: tissue induction, hormonal regulation and cell type specification
Toivanen, R., & Shen, M. M. (2017) · Development · doi:10.1242/dev.148270 · Cited by 202
Parker, D. C., Folpe, A. L., Bell, J., Oliva, E., Young, R. H., Cohen, C., & Amin, M. B. (2003) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200301000-00001 · Cited by 195
Hayward, S. W., Haughney, P. C., Rosen, M. A., Greulich, K. M., Weier, H.-U. G., Dahiya, R., & Cunha, G. R. (1998) · Differentiation · doi:10.1046/j.1432-0436.1998.6330131.x · Cited by 191
Liubomirski, Y., Lerrer, S., Meshel, T., Rubinstein-Achiasaf, L., Morein, D., Wiemann, S., Körner, C., & Ben-Baruch, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00757 · Cited by 184
Integrins in prostate cancer progression
Goel, H. L., Li, J., Kogan, S., & Languino, L. R. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0019 · Cited by 180
Modes of invasion during tumour dissemination
Pandya, P., Orgaz, J. L., & Sanz‐Moreno, V. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12019 · Cited by 174
Lang, S. H., Hyde, C., Reid, I. N., Hitchcock, I. S., Hart, C. A., Gordon Bryden, A. A., Villette, J., Stower, M. J., & Maitland, N. J. (2002) · The Prostate · doi:10.1002/pros.10088 · Cited by 170
Cancer-associated fibroblasts: The chief architect in the tumor microenvironment
Sarkar, M., Nguyen, T., Gundre, E., Ogunlusi, O., El-Sobky, M. H., Giri, B., & Sarkar, T. R. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1089068 · Cited by 166
TNF‐α enhances TGF‐β‐induced endothelial‐to‐mesenchymal transition via TGF‐β signal augmentation
Yoshimatsu, Y., Wakabayashi, I., Kimuro, S., Takahashi, N., Takahashi, K., Kobayashi, M., Maishi, N., Podyma‐Inoue, K. A., Hida, K., Miyazono, K., et al. (2020) · Cancer Science · doi:10.1111/cas.14455 · Cited by 162
Ko, C., Huang, C.-C., Lin, H.-Y., Juan, C.-P., Lan, S., Shyu, H., Wu, S., Hsiao, P., Huang, H., Shun, C., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3297 · Cited by 159
Impact of Epithelial–Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ
Strell, C., Paulsson, J., Jin, S.-B., Tobin, N. P., Mezheyeuski, A., Roswall, P., Mutgan, C., Mitsios, N., Johansson, H., Wickberg, S. M., et al. (2019) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djy234 · Cited by 158
Mechanisms of Therapeutic Resistance in Prostate Cancer
Nakazawa, M., Paller, C., & Kyprianou, N. (2017) · Current Oncology Reports · doi:10.1007/s11912-017-0568-7 · Cited by 154
Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in Cancer and Cancer Immunotherapy
Raskov, H., Orhan, A., Gaggar, S., & Gögenur, I. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.668731 · Cited by 150
Stromal integrin α11 regulates PDGFRβ signaling and promotes breast cancer progression
Primac, I., Maquoi, E., Blacher, S., Heljasvaara, R., Van Deun, J., Smeland, H. Y. H., Canale, A., Louis, T., Stuhr, L., Sounni, N. E., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125890 · Cited by 147
Heterogeneity of stromal fibroblasts in tumor
Orimo, A., & Weinberg, R. A. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.4.4255 · Cited by 143
Wikström, P., Marusic, J., Stattin, P., & Bergh, A. (2009) · The Prostate · doi:10.1002/pros.20927 · Cited by 142
Rabinovitz, I., Nagle, R. B., & Cress, A. E. (1995) · Clinical & Experimental Metastasis · doi:10.1007/bf00118187 · Cited by 134
Type I Collagen Receptor (α2β1) Signaling Promotes Prostate Cancer Invasion through RhoC GTPase
Hall, C. L., Dubyk, C. W., Riesenberger, T. A., Shein, D., Keller, E. T., & van Golen, K. L. (2008) · Neoplasia · doi:10.1593/neo.08380 · Cited by 132
Periostin: biology and function in cancer
Dorafshan, S., Razmi, M., Safaei, S., Gentilin, E., Madjd, Z., & Ghods, R. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02714-8 · Cited by 131
Recent advances in lung-on-a-chip models
Francis, I., Shrestha, J., Paudel, K. R., Hansbro, P. M., Warkiani, M. E., & Saha, S. C. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.06.004 · Cited by 124
Vimentin affects the mobility and invasiveness of prostate cancer cells
Zhao, Y., Yan, Q., Long, X., Chen, X., & Wang, Y. (2008) · Cell Biochemistry and Function · doi:10.1002/cbf.1478 · Cited by 117
Qin, X., Yan, M., Zhang, J., Wang, X., Shen, Z., Lv, Z., Li, Z., Wei, W., & Chen, W. (2016) · Scientific Reports · doi:10.1038/srep20587 · Cited by 117
Castelló-Cros, R., & Cukierman, E. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-59745-413-1_19 · Cited by 112
Rao, B., Narasimhan, M., Narashiman, S., & Rajan, S. T. (2014) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2014/7820.4231 · Cited by 112
Fong, E. L. S., Wan, X., Yang, J., Morgado, M., Mikos, A. G., Harrington, D. A., Navone, N. M., & Farach-Carson, M. C. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.10.059 · Cited by 111
Wang, R., Xu, J., Juliette, L., Castilleja, A., Love, J. E., Sung, S., Zhau, H. E., Goodwin, T. J., & Chung, L. W. K. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.05.005 · Cited by 103
Tissue architecture in tumor initiation and progression
Almagro, J., Messal, H. A., Elósegui-Artola, A., van Rheenen, J., & Behrens, A. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.02.007 · Cited by 101
Microfluidic Organoids-on-a-Chip: Quantum Leap in Cancer Research
Duzagac, F., Saorin, G., Memeo, L., Canzonieri, V., & Rizzolio, F. (2021) · Cancers · doi:10.3390/cancers13040737 · Cited by 96
3d organ-on-a-chip: the convergence of microphysiological systems and organoids
Baptista, L. S., Porrini, C., Kronemberger, G. S., Kelly, D. J., & Perrault, C. M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1043117 · Cited by 90
Yang, X. J., Lecksell, K., Gaudin, P. B., & Epstein, J. I. (1999) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199902000-00002 · Cited by 89
Prostate-Specific Antigen, High-Molecular-Weight Cytokeratin (Clone 34βE12), and/or p63
Kunju, L. P., Mehra, R., Snyder, M. L., & Shah, R. B. (2006) · American Journal of Clinical Pathology · doi:10.1309/v1ry91nkx5arw2q5 · Cited by 88
Periostin is up-regulated in high grade and high stage prostate cancer
Tischler, V., Fritzsche, F. R., Wild, P. J., Stephan, C., Seifert, H., Riener, M., Hermanns, T., Mortezavi, A., Gerhardt, J., Schraml, P., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-273 · Cited by 86
Clark, A. K., Taubenberger, A. V., Taylor, R. A., Niranjan, B., Chea, Z. Y., Zotenko, E., Sieh, S., Pedersen, J. S., Norden, S., Frydenberg, M., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.005 · Cited by 69
Kahane, H., Sharp, J. W., Shuman, G. B., Dasilva, G., & Epstein, J. I. (1995) · Urology · doi:10.1016/s0090-4295(99)80118-6 · Cited by 69
Yoshioka, N. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5590 · Cited by 69
Kim, J. J., Yin, B., Christudass, C. S., Terada, N., Rajagopalan, K., Fabry, B., Lee, D. Y., Shiraishi, T., Getzenberg, R. H., Veltri, R. W., et al. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24464 · Cited by 67
“Stromal cells in prostate cancer pathobiology: friends or foes?”
Pederzoli, F., Raffo, M., Pakula, H., Ravera, F., Nuzzo, P. V., & Loda, M. F. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-02085-x · Cited by 62
Li, J., Jia, Z., Kong, J., Zhang, F., Fang, S., Li, X., Li, W., Yang, X., Luo, Y., Lin, B., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0150247 · Cited by 61
Neri, S., Miyashita, T., Hashimoto, H., Suda, Y., Ishibashi, M., Kii, H., Watanabe, H., Kuwata, T., Tsuboi, M., Goto, K., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.02.026 · Cited by 59
Tsunoda, T., Furusato, B., Takashima, Y., Ravulapalli, S., Dobi, A., Srivastava, S. K., McLeod, D. G., Sesterhenn, I. A., Ornstein, D. K., & Shirasawa, S. (2009) · The Prostate · doi:10.1002/pros.20988 · Cited by 58
New targets for therapy in prostate cancer: modulation of stromal–epithelial interactions
Chung, L. W. K., Hsieh, C., Law, A., Sung, S., Gardner, T. A., Egawa, M., Matsubara, S., & Zhau, H. E. (2003) · Urology · doi:10.1016/s0090-4295(03)00796-9 · Cited by 56
Wang, R., Sun, X., Wang, C. Y., Hu, P., Chu, C.-Y., Liu, S., Zhau, H. E., & Chung, L. W. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042653 · Cited by 56
The Role of Alpha 6 Integrin in Prostate Cancer Migration and Bone Pain in a Novel Xenograft Model
King, T. E., Pawar, S. C., Majuta, L., Sroka, I. C., Wynn, D., Demetriou, M. C., Nagle, R. B., Porreca, F., & Cress, A. E. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003535 · Cited by 51
Nuzzo, P. V., RUBAGOTTI, A., Zinoli, L., Ricci, F., Salvi, S., Boccardo, S., & Boccardo, F. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-625 · Cited by 51
On the orders of magnitude of epigenic dynamics and monoclonal antibody production
Savinell, J. M., Lee, G. M., & Palsson, B. Ø. (1989) · Bioprocess and Biosystems Engineering · doi:10.1007/bf00369177 · Cited by 48
Storch, K. N., Taatjes, D. J., Bouffard, N. A., Locknar, S. A., Bishop, N. M., & Langevin, H. M. (2007) · Histochemistry and Cell Biology · doi:10.1007/s00418-007-0275-9 · Cited by 46
Berger, P. L., Frank, S. B., Schulz, V. V., Nollet, E. A., Edick, M. J., Holly, B., Chang, T.-T. A., Hostetter, G. H., Kim, S., & Miranti, C. K. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3076 · Cited by 43
Self-citationAnggorowati, N., Kurniasari, C. R., Damayanti, K., Cahyanti, T., Widodo, I., Ghozali, A., Romi, M. M., Sari, D. C. R., & Arfian, N. (2017) · Europe PMC (PubMed Central) · doi:10.22034/apjcp.2017.18.3.667 · Cited by 43
Periostin promotes secretion of fibronectin from the endoplasmic reticulum
Kii, I., Nishiyama, T., & Kudō, A. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.01.139 · Cited by 40
α-smooth muscle actin-positive fibroblasts correlate with poor survival in hepatocellular carcinoma
Parikh, J. G., Kulkarni, A. L., & Johns, C. (2013) · Oncology Letters · doi:10.3892/ol.2013.1720 · Cited by 37
Gillard, M., Javier, R., Ji, Y., Zheng, S. L., Xu, J., Brendler, C. B., Crawford, S. E., Pierce, B. L., Griend, D. J. V., & Franco, O. E. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3810 · Cited by 37
Overexpression of Periostin in Stroma Positively Associated with Aggressive Prostate Cancer
Tian, Y., Choi, C. H., Li, Q. K., Rahmatpanah, F. B., Chen, X., Kim, S. R., Veltri, R. W., Chia, D., Zhang, Z., Mercola, D., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121502 · Cited by 36
SUPPRESSION OF ANTIGEN-SPECIFIC LYMPHOCYTE ACTIVATION IN MODELED MICROGRAVITY
COOPER, D., Pride, M. W., Brown, E. L., Risin, D., & Pellis, N. R. (2001) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1290/1071-2690(2001)037<0063:soasla>2.0.co;2 · Cited by 33
Estimating the rate and reasons of clinical trial failure in urologic oncology
Stensland, K. D., DePorto, K. A., Ryan, J., Kaffenberger, S. D., Reinstatler, L. S., Galsky, M. D., Canes, D., Skolarus, T. A., & Moinzadeh, A. (2020) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2020.10.070 · Cited by 32
Human stroma and epithelium co-culture in a microfluidic model of a human prostate gland
Jiang, L., Ivich, F., Tahsin, S., Tran, M., Frank, S. B., Miranti, C. K., & Zohar, Y. (2019) · Biomicrofluidics · doi:10.1063/1.5126714 · Cited by 31
Self-citationNollet, E. A., Cardó‐Vila, M., Ganguly, S. S., Tran, J. D., Schulz, V. V., Cress, A. E., Corey, E., & Miranti, C. K. (2020) · Oncogene · doi:10.1038/s41388-020-1370-9 · Cited by 29
Self-citationInteraction of prostate carcinoma-associated fibroblasts with human epithelial cell lines in vivo
Sasaki, T., Franco, O. E., & Hayward, S. W. (2017) · Differentiation · doi:10.1016/j.diff.2017.07.002 · Cited by 24
Preprostatectomy: A clinical model to study stromal-epithelial interactions
Lopaczynski, W., Hruszkewycz, A. M., & Lieberman, R. (2001) · Urology · doi:10.1016/s0090-4295(00)00973-0 · Cited by 20
Cancer Cell–Extrinsic Roles for the Androgen Receptor in Prostate Cancer
Hahn, A. W., Siddiqui, B. A., Leo, J., Dondossola, E., Basham, K. J., Miranti, C. K., & Frigo, D. E. (2023) · Endocrinology · doi:10.1210/endocr/bqad078 · Cited by 19
Self-citationRubenstein, C. S., Gard, J. M. C., Wang, M., McGrath, J., Ingabire, N., Hinton, J. P., Marr, K. D., Simpson, S. J., Nagle, R. B., Miranti, C. K., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0868 · Cited by 17
Self-citationCancer‐stromal cell fusion as revealed by fluorescence protein tracking
Wang, R., Lewis, M. S., Lyu, J., Zhau, H. E., Pandol, S. J., & Chung, L. W. K. (2019) · The Prostate · doi:10.1002/pros.23941 · Cited by 16
Integrative Analysis of Periostin in Primary and Advanced Prostate Cancer
Cattrini, C., Barboro, P., RUBAGOTTI, A., Zinoli, L., Zanardi, E., Capaia, M., & Boccardo, F. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100789 · Cited by 15
Multhaupt, H. A. B., Fessler, J. N., & Warhol, M. J. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-1764-lohmwc · Cited by 14
Altered TGF‐α/β signaling drives cooperation between breast cancer cell populations
Franco, O. E., Tyson, D. R., Konvinse, K. C., Udyavar, A. R., Estrada, L., Quaranta, V., Crawford, S. E., & Hayward, S. W. (2016) · The FASEB Journal · doi:10.1096/fj.201500187rr · Cited by 13
Novel patient-derived 3D culture models to guide clinical decision-making in prostate cancer
Hemelryk, A. V., & van Weerden, W. M. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.02.005 · Cited by 12
Considerations in the Analysis of Clinical Trial Failure
Stensland, K. D., Daignault‐Newton, S., & Skolarus, T. A. (2021) · The Journal of Urology · doi:10.1097/ju.0000000000002206 · Cited by 4
Lu, J. G., Lo, E. T., Williams, C., Ma, B., Sherrod, A. E., & Xiao, G. (2022) · The Prostate · doi:10.1002/pros.24478 · Cited by 4
Research works printed but not linked: 1
- Rao K. B. Malathi N. Narashiman S. Rajan S. T. (2014). Evaluation of myofibroblasts by expression of alpha smooth muscle actin: a marker in fibrosis, dysplasia and carcinoma. J. Clin. Diagnostic Res. 8, ZC14– ZC17. 10.7860/JCDR/2014/7820.4231 PMC4064839 24959509 · DOI
Cited by
Cancer cell membrane-coated nanoparticles: a promising anti-tumor bionic platform
Guo, Q., Wang, S., Xu, R., Tang, Y., & Xia, X. (2024) · RSC Advances · doi:10.1039/d4ra01026d · Cited by 123
Organ-on-a-Chip Applications in Microfluidic Platforms
An, L., Liu, Y., & Liu, Y. (2025) · Micromachines · doi:10.3390/mi16020201 · Cited by 79
Cancer-on-a-chip for precision cancer medicine
Liu, L., Wang, H., Chen, R., Song, Y., Wei, W., Baek, D. S. H., Gillin, M., Kurabayashi, K., & Chen, W. (2025) · Lab on a Chip · doi:10.1039/d4lc01043d · Cited by 52
In vitro and in vivo experimental models for cancer immunotherapy study
Zhang, C., Sui, Y., Liu, S., & Yang, M. J. (2024) · Current Research in Biotechnology · doi:10.1016/j.crbiot.2024.100210 · Cited by 53
Imaging 3D cell cultures with optical microscopy
Hsieh, H.-C., Han, Q., Brenes, D., Bishop, K. W., Wang, R., Wang, Y., Poudel, C., Glaser, A. K., Freedman, B., Vaughan, J. C., et al. (2025) · Nature Methods · doi:10.1038/s41592-025-02647-w · Cited by 49
Metadata
- Authors
- Jiang, L., Khawaja, H., Tahsin, S., Clarkson, T. A., Miranti, C. K., & Zohar, Y.
- Affiliations
- University of Arizona (US)
- Corresponding author
- Jiang, Linan
- Venue
- Frontiers in Bioengineering and Biotechnology
- Publisher
- Frontiers Media SA
- Published
- 2024-01-23
- Volume
- 12
- Pages
- 1302223-1302223
- ISSN
- 2296-4185 (ISSN-L)
- PMC
- PMC10844564
- OpenAlex
- W4391144178
- Cited by
- 26
- References
- 102
- Citations by year
- 2026: 9 · 2025: 11 · 2024: 6
- FWCI
- 2.86
- Type
- journal article
- Language
- en
- Update notices
- corrigendum (2024-11-12)
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Bioengineering and Biotechnology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UA Campus Repository (The University of Arizona) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- University of Washington
- National Cancer Institute (T32CA009213, R01CA254200, U54CA143924)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- prostate cancer, tumor-stroma interactions, cancer-associated fibroblasts, stromal fibroblasts, androgen receptor, androgen deprivation therapy resistance, bone metastasis, tumor invasion, in vitro disease model
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.